0000000000336709

AUTHOR

Martin Meyer

showing 2 related works from this author

Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage.

2012

Population-based studies on ovarian cancer providing survival estimates by age, histology, laterality, and stage have been sparse. We aimed to derive the most up-to-date and detailed survival estimates for ovarian cancer patients in Germany. We used a pooled German national dataset including data from 11 cancer registries covering 33 million populations. A total of 21 651 patients diagnosed with ovarian cancer in 1997-2006 were included. Period analysis was carried out to calculate the 5-year relative survival (RS) for the years 2002-2006. Trends in survival between 2002 and 2006 were examined using model-based period analysis. Age adjustment was performed using five age groups (15-44, 45-5…

AdultCancer Researchmedicine.medical_specialtyAdolescentDatabases FactualEpidemiologyPopulationAge adjustmentYoung AdultGermanymedicineCarcinomaHumansYoung adulteducationAgedDemographyNeoplasm StagingGynecologyOvarian Neoplasmseducation.field_of_studyRelative survivalbusiness.industryNot Otherwise SpecifiedPublic Health Environmental and Occupational HealthAge FactorsCancerMiddle Agedmedicine.diseaseSurvival RateOncologyFemaleOvarian cancerbusinessEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
researchProduct

Survival for patients with rare haematologic malignancies: Changes in the early 21st century

2017

Abstract Introduction Population-level survival has improved for common haematologic malignancies in the early 21st century. However, relatively few population-level data are available for rare haematologic malignancies. Methods Data were extracted from 12 cancer registries in Germany and the Surveillance, Epidemiology and End Results database in the United States (US). Cases of haematologic malignancies with an incidence of less than 1 per 100,000 were selected for analysis. Period analysis was used to determine 5-year relative survival (RS) for the years 2003–2012, and modelled period analysis was used to determine changes in survival between 2003–2007 and 2008–2012. Results Seven individ…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyPathologyTime FactorsAdolescentAnaplastic LymphomaYoung Adult03 medical and health sciencesRare Diseases0302 clinical medicineGermanyInternal medicineHumansMedicineRegistriesHealthcare DisparitiesYoung adultSurvival analysisAgedMycosis fungoidesRelative survivalbusiness.industryIncidenceIncidence (epidemiology)CancerMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesTreatment OutcomeOncologyHematologic Neoplasms030220 oncology & carcinogenesisFemaleMantle cell lymphomabusinessSEER Program030215 immunologyEuropean Journal of Cancer
researchProduct